News
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
A new care center for homeless people on Los Angeles' infamous Skid Row embraces the principle of harm reduction, a more ...
The country’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, the UK’s official system for ...
Demand for weight-loss drugs is rising at a fast clip in India where rivals Eli Lilly and Novo Nordisk are competing for ...
GLP-1 drugs like Ozempic may have much more serious, and even potentially deadly, side effects than originally thought.
Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...
The arrests were made after complaints from the business community about drug distribution and drug use in the area of ...
As Chinese-developed drugs draw U.S. interest, a regulatory chill threatens to dampen new investment
Those questions, experts say, are based on the Trump administration’s hawkish approach to China generally, as well as on a ...
Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...
Drugs crisis in jails ‘worse than ever’ as seizures by prison officers near record-high - Exclusive: Blue-light emergency ...
The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.
Officials said three juveniles were removed from the SUV while a K-9 deputy did a sniff search. In the car, they found a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results